相关实验视频

Updated: Jan 12, 2026

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram

Published on: November 27, 2016

转录组学和蛋白质组学确定了血清素转运体作为基本震的有希望的治疗标

Lingbing Wang¹, Zhuofan Zhou¹, Suzhen Lin¹

¹Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Molecular & cellular proteomics : MCP

|November 5, 2025

概括

基本震 (ET) 研究显示,小脑中血清载体 (SERT) 的上调导致血清水平降低,导致震. 针对SERT可能为这种常见的运动障碍提供新的治疗策略.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

基本震 (ET) 是一种常见的运动障碍,与小脑功能障碍有关.
目前对ET的治疗方法有限,原因是对其分子基础的不完全理解.
哈马林诱导的震小鼠模型对于研究ET机制至关重要.

研究的目的:

在harmaline诱导的震模型中研究小脑功能障碍的分子机制.
确定涉及ET病原发生的关键分子参与者.
探索潜在的治疗的潜在治疗.

主要方法:

结合液体染色学-质谱学/质谱学 (LC-MS/MS) 和RNA测序 (RNA-Seq) 进行鼠标小脑的多omics分析.
进行KEGG通路丰富分析,以识别显著失调的分子.
药物抑制和基因淘汰的血清素载体 (SERT).

主要成果:

确定了5194个相关的编码分子,其中19个在harmaline模型中显著失调.
脑小叶血清素载体 (SERT) 被确定为一个关键分子.
在小脑Purkinje细胞中验证了SERT升高调节,导致在SERT抑制或淘汰后,血清激素耗尽,震减弱.

结论:

在小脑中由harmaline诱导的SERT上调有助于病原因,通过耗尽血清激素水平.
SERT代表了一个潜在的分子标,用于开发针对基本震的新型治疗干预措施.
这项研究为基本震的分子病理学提供了关键的见解.

关键词:

基本震是一种基本的震.蛋白质组分析蛋白质组分析血清素的运输体是血清素的运输体.治疗目标是治疗的目标.转录基因序列测序转录基因序列测序

更多相关视频

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

$MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor$ 05:54

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on: December 13, 2017

相关概念视频

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

Drugs Affecting Neurotransmitter Release or Uptake

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...

Classification of Neurotransmitters

Classification of Neurotransmitters

Neurotransmitters play a crucial role in the communication between neurons in the autonomic nervous system. Neurons in the autonomic nervous system can be cholinergic or adrenergic depending on the neurotransmitters synthesized. Cholinergic neurons use acetylcholine as their primary neurotransmitter. This includes all the preganglionic fibers of the sympathetic and pre- and postganglionic fibers of the parasympathetic nervous systems. In addition, neurons of the somatic nervous system also use...